Healthcare

China is one of the largest emerging markets in healthcare industry. The goal of the healthcare panel is to promote the communication and cooperation between U.S. and China in healthcare sector. We will bring healthcare leaders and experts to discuss policy changes, health IT and biotechnology development, and investment opportunities in a transitioning time. What lessons could we learn from healthcare reforms of the U.S. and China? Will these regulation changes bring any opportunities or risks for global healthcare companies to invest in emerging markets? How could innovative technology solutions such as Electronic Health Record (EHR) improve health outcomes and efficiency?

Rema Padman is the Professor of Management Science and Healthcare Informatics in the H. John Heinz III College at Carnegie Mellon University in Pittsburgh. She is also a Thrust Leader of Health Informatics Research at iLab at the Heinz College, Adjunct Professor in the Department of Biomedical Informatics at the University of Pittsburgh School of Medicine, and Honorary Professor in the School of Health Sciences at the University of Salford in UK. She received PhD in Operations Research from the University of Texas at Austin and National Library of Medicine Senior Fellowship in Applied Informatics from The University of Pittsburgh School of Medicine. Dr. Padman’s current research examines healthcare operations and decision support, privacy and confidentiality, and process modeling and risk analysis, in the context of information technology interventions in healthcare delivery and management, such as eHealth, mHealth and chronic disease management. Her research has appeared in many scholarly journals and has been funded by the National Science Foundation, National Library of Medicine, and the Centers for Disease Control, among others. She has served on review panels for the National Science Foundation and the National Institutes of Health in the US, and the Medical Research Council in the UK and on the editorial board of major academic journals.

Dr. Alan Paau is Vice Provost for Technology Transfer and Economic Development at Cornell University with responsibilities both at the medical campus in Manhattan and at the general campus in Ithaca, New York. He is also Executive Director of the Cornell Center for Technology Enterprise and Commercialization, and President of the Cornell Research Foundation, Inc. Until 1994, he was Associate Director of the Biotechnology Center at the Ohio State University with responsibilities in research administration, technology management, and industry liaison. Dr. Paau held faculty appointments while at Iowa State University in the departments of Preventive Medicine, Immunology & Microbiology, and Genetics & Zoology, and at the Ohio State University in the departments of Microbiology, and Plant Pathology. Before returning to the academic environment in 1992, Dr. Paau held various research and management positions of increasing responsibilities in the Cetus Corporation and the W.R. Grace & Co. organizations for 12 years. He is the inventor to 8 US patents. As a director of intellectual property and a licensing executive, he supervised the execution of over 1100 licenses and option agreements and the formation of over 120 startup companies using university innovations.

Dr. Yan Kang is the Dean of Sino-Dutch Biomedical and Information Engineering School at Northeastern University, Deputy director of the Key Laboratory of Medical Imaging & Computing of Ministry of Education. He is also the director of the Institute of Health Research at Neusoft Xikang Healthcare Company and the Chief Knowledge Officer of the Medical IT Division, Neusoft Group. He earned his Ph.D. degree in the Institute of Medical Physics, University of Erlangen-Nuernberg, Germany in 2002. He worked in the Laboratory of Image Guided Surgery, Stanford University as a postdoctoral scholar in 2004. His research activities have been focused on medical imaging, Molecular Imaging, Computer Intelligent Assistance, Medicine Computer Simulation. He is the Principal Investigator of several NSFC and national key projects. He presided in developing several Computer Intelligent Assistant software products (passed SFDA, CE, and FDA certifications), 15 patents (13 domestic and 2 international). Neusoft MammoCAD computer-aided diagnostic product filled the domestic blank. The UroCARE software is the first FDA certified software product from China. He has published about 100 papers and a book translation.

Dr. Cary Wu is associate medical and scientific director, International & Commercial Services Division, University of Pittsburgh Medical Center (UPMC). Dr. Wu has been actively involved in UPMC activities in China. In addition, Dr. Wu is Lombardi and Shinozuka Experimental Pathology Research Chair and Professor in the Department of Pathology, the University of Pittsburgh School of Medicine. Prior to coming to Pittsburgh in 2000, Dr. Wu was a faculty member at the University of Alabama at Birmingham and an associate consultant at Mayo Clinic Scottsdale. Dr. Wu has a strong background in biomedical sciences and is a principle investigator of NIH-funded research projects. Dr. Wu has received several awards including Edward C. Kendall Alumni Award for Meritorious Research, Mayo Foundation, Edward Livingston Trudeau Scholar, American Lung Association and Pitt Innovator Award. He holds a B.S. and a M.S. from the East China University of Science and Technology in Shanghai, and a Ph.D. from the University of Pittsburgh.

Daniel Bishop is an entrepreneur and graduate student with a passion for improving healthcare. He is Chief Innovation Officer and Co-Founder of Qualaris Healthcare Solutions, Inc., an early-stage health IT company based in Pittsburgh, PA. Daniel leads Qualaris in designing and delivering software solutions to hospitals for improving key clinical practices in delivering safe patient care. Daniel is currently an MD/PhD candidate at University of Pittsburgh and Carnegie Mellon University. He previously co-founded IACT (Industry Academics Clinicians Together), a grassroots healthcare innovation organization, and he currently sits on the Board of Directors at Health Careers Futures, a healthcare workforce non-profit based in western PA. Daniel graduated summa cum laude with his BSE in Bioengineering from Arizona State University where received the distinction of “top researcher” for inventing a non-invasive glucose meter now in translational studies with the Mayo Clinic. Outside of work, Daniel is an avid cook, amateur guitarist, and collector of fountain pens.